Asia Pacific Brain Health Supplements Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Natural Molecules, Herbal Extract, and Vitamins and Minerals), Application (Memory Enhancement, Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-Aging and Longevity, and Others), Dosage Form (Capsules, Tablets, and Others), Distribution Channel (Supermarket and Hypermarket, Drug Store, Online, and Others), and Age Category (Adults, Children, and Elderly)
The Asia Pacific brain health supplements market is expected to grow from US$ 1,506.36 million in 2022 to US$ 3,049.40 million by 2028; it is estimated to grow at a CAGR of 12.5% from 2022 to 2028.
Growing Potential in Developing Countries Provides Opportunities to Market Players
Leading companies in the brain health supplements market are focused on increasing their reach across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities to key brain health supplement manufacturers in the future. This can be attributed to the availability of a large patient pool with the growing elderly population; the high prevalence of depression, anxiety, mood swings, and other mental & cognitive disorders; increasing levels of disposable income; and improving infrastructure in the healthcare sector. Asia Pacific has become a business-friendly and adaptable hub due to relatively less stringent regulations and data requirements. Further, high investments by governments in these countries in life science and health research favor the upgrading of facilities with the latest technologies. Thus, progressive healthcare sectors in developing countries are likely to favor the Asia Pacific brain health supplements market in the coming years.
Asia Pacific Brain Health Supplements Market Overview
The Asia Pacific brain health supplements market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to the growing mental illness, surging geriatric population, and increasing product launches by key players. The rising awareness about mental health, coupled with the prevalence of mental health disorders, is bolstering the brain health supplements market in China.
Asia Pacific Brain Health Supplements Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Brain Health Supplements Market Segmentation
The Asia Pacific brain health supplements market is segmented on the basis of product, application, dosage form, distribution channel, age category, and country.
Based on product, the Asia Pacific brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held the largest market share in 2022. Further, natural molecule is segmented as acetyl-carnitine, citicoline, huperzine-A, alpha GPC, docosahexaenoic acid (DHA), and others. Additionally, herbal extract is further segmented as ginseng, curcumin, lion's mane, ginkgo biloba, bacopa monnieri, and others. Further, vitamins & minerals is further sub-segmented as vitamins C & E, vitamin B complex, and others.
Based on application, the Asia Pacific brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held the largest market share in 2022.
Based on dosage form, the Asia Pacific brain health supplements market is segmented into capsules, tablets, and others . The others segment held the largest market share in 2022.
Based on distribution channel, the Asia Pacific brain health supplements market is segmented into supermarket and hypermarket, drug store, online, and others . The supermarket and hypermarket segment held the largest market share in 2022.
Based on age category, the Asia Pacific brain health supplements market is segmented into adults, children, and elderly . The adults segment held the largest market share in 2022.
The Asia Pacific brain health supplements market, by country, is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.
Danone SA; Unilever PLC; Purelife bioscience Co., Ltd.; and Harbin Pharmaceutical Group Co., Ltd. are the leading companies operating in the Asia Pacific brain health supplements market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific brain health supplements market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific brain health supplements market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific brain health supplements market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook